# Corticosteroids as Rescue Therapy for the Late Phase of Acute Respiratory Distress Syndrome

> **NCT00295269** · PHASE3 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 200 (—)

## Conditions studied

- Acute Respiratory Distress Syndrome
- Lung Diseases

## Interventions

- **DRUG:** Mythylprednisolone

## Key facts

- **NCT ID:** NCT00295269
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-03
- **Primary completion:** —
- **Final completion:** 2005-09
- **Target enrollment:** 200 (—)
- **Last updated:** 2006-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00295269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00295269, "Corticosteroids as Rescue Therapy for the Late Phase of Acute Respiratory Distress Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00295269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*